Investors in the Cannabis Market: Page 4

Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

The net proceeds of the offering will be used for general corporate purposes, which may include opportunistically reducing debt.

Eve & Co Announces CAD$1M Private Financing

The financing has a two-year term and is to be received in two equal tranches of CAD$500,000.

A Look at BIPOC’s Ability to Access Capital and Income Through Cannabis in 2020

Industry stakeholders discuss developments that will support minority businesses and investors looking to provide financial support to disenfranchised communities.

Gage Cannabis Announces $20-Million Reg A+ Commitment from JW Asset Management

JW Asset Management's investment will provide Gage with resources to accelerate the expansion of its retail and cultivation footprint, as well as pursue accretive acquisitions.

Verano Holdings Enters Into an Agreement for a Go-Public Transaction in Conjunction with AltMed Merger

The transaction will be effected by Verano participating in a reverse takeover of Majesta Minerals Inc.

10 Notable M&A Deals That Happened (and Didn’t) in 2020

Lower valuations and the coronavirus pandemic made for an interesting year of mergers and acquisitions in cannabis. Here, we look back on this year’s most talked-about transactions.

WM Holding Company, LLC to List on Nasdaq Through Merger with Silver Spike Acquisition Corp.

WM Holding Company operates Weedmaps and WM Business, a comprehensive software-as-a-service subscription offering for cannabis retailers and brands.

Corporate Cannabis Q3: Getting Back to Baseline

Most MSOs saw an increase in net and gross revenues this past quarter, and costs came down across the board.

Intrinsic Capital Partners Raises $102M for Cannabis and Hemp-Related Investment

The Pennsylvania-based firm has already committed $65 million to ancillary businesses such as Treez and Hound Labs.

Corporate Cannabis Q2: Revenue Growth Steady, Profits Still Out of Reach

Big questions remain about corporate cannabis performance for the balance of 2020, with physical retail sales likely to be impacted until 2021—possibly beyond.

How To Evaluate New Markets

A model to help you gauge emerging opportunities, minimize risk and increase your chances of success.

How We Got Here: The Financial Evolution of Commercial Cannabis

This special three-part series reflects on legislative, financial and regulatory developments that have altered state-legal cannabis programs during the past decade. Part II looks at how capital and investors shaped today’s market, and what that trajectory might mean for the industry’s future.

Previous Page

Page 4 of 22

Next Page